Venetoclax in the Treatment of Multiple Myeloma: A Retrospective Analysis of 79 Patients

E Zolotov, V Patel, Y Weiss, N Biran… - European Journal of …, 2024 - Wiley Online Library
Venetoclax, the first‐in‐class BCL‐2 inhibitor, has shown efficacy in multiple myeloma (MM),
particularly in patients with the t (11; 14) translocation. This single‐center retrospective …

Navigating a Paradigm Shift Venetoclax Treatment Redefines Landscape of Acute Myeloid Leukemia.

MH Gul, AR Siddiqui, F Zehra… - Oncology …, 2024 - search.ebscohost.com
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the
accumulation of malignant myeloid progenitor hematopoietic cells in the bone marrow and …